The LEAPS Project of the MIT NEWDIGS initiative is actively soliciting Use Cases for our workstream focused on methods innovation associated with “Integrating Evidence Using Meta-Analytic Approaches.” This methodology is … Read More
Rebranding: Adaptive Reimbursement is now Precision Reimbursement
Adaptive Reimbursement evolved as a collaboration of our NEWDIGS LEAPS and FoCUS Projects. The goal of LEAPS is to advance the knowledge and practice of Precision Medicine by modernizing how … Read More
FoCUS Monthly Recap: June 2021
NEW WHITE PAPER Emerging market solutions for financing and reimbursement of durable cell and gene therapies The white paper reports the findings and analysis from a survey of organizations offering … Read More
LEAPS Monthly Recap: June 2021
DESIGN LAB LEAPS virtual Design Lab highlights growth of the project from design to action with Testbed activities A virtual Design Lab held on June 10 and 11 highlighted progress … Read More
LEAPS virtual Design Lab highlights growth of the project from design to action with Testbed activities
A virtual Design Lab held on June 10 and 11 highlighted progress made in moving from design to application of key elements of a LEAPS learning system within our safe … Read More
Dr. Kay Larholt speaks on USC panel “Measuring Real-World Effectiveness and Value”
The USC Leonard D. Schaeffer Center for Health Policy & Economics has featured a four-part series on precision medicine. On June 17th Dr. Kay Larholt, Director of Research for NEWDIGS, was … Read More
Eric Small recognized with MIT Excellence Award
Eric Small, Senior Administrative Assistant for the Center for Biomedical Innovation, was recognized with an Outstanding Contributor Award in the 2021 MIT Excellence Awards. He was cited for his “empathy, … Read More
LEAPS Monthly Recap: May 2021
SPECIAL DESIGN LAB LEAPS hosts special Design Lab on COVID-19 Long-Haulers On May 19, 2021, LEAPS hosted a virtual Design Lab on behalf of MIT Lincoln Labs, DTRA (the Defense … Read More
FoCUS Monthly Recap: May 2021
NEW MEMBER CSL Behring joins FoCUS “CSL Behring strengthens our consortium’s perspectives on how to achieve patient impact with cutting-edge therapies,” said Gigi Hirsch, MD, executive director of NEWDIGS. “The … Read More
CSL Behring joins NEWDIGS FoCUS Project
Collaboration to improve accessibility and sustainability of new cell and gene therapiesThursday, May 27, 2021 Global biotherapeutic leader CSL Behring has joined the Massachusetts Institute of Technology Center for Biomedical Innovation’s New … Read More